Your session is about to expire
← Back to Search
Intraperitoneal Group for Vaginal Vault Prolapse
N/A
Waitlist Available
Led By Tristi Muir, MD
Research Sponsored by The Methodist Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 month
Awards & highlights
Study Summary
This trial is comparing two different approaches to surgery for a vaginal prolapse that can occur after a hysterectomy.
Eligible Conditions
- Vaginal Vault Prolapse
- Vaginal Prolapse
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Operative time (minutes)
Secondary outcome measures
Estimated blood loss (ml)
Frequency of perioperative complications (%)
Hospital length of stay (hours)
+13 moreTrial Design
2Treatment groups
Active Control
Group I: Intraperitoneal GroupActive Control1 Intervention
Vaginal intraperitoneal uterosacral ligament suspension group
Group II: Extraperitoneal GroupActive Control1 Intervention
Vaginal extraperitoneal uterosacral ligament suspension group
Find a Location
Who is running the clinical trial?
The Methodist Hospital Research InstituteLead Sponsor
275 Previous Clinical Trials
80,497 Total Patients Enrolled
Tristi Muir, MDPrincipal InvestigatorThe Methodist Hospital Research Institute
Danny Mounir, MDPrincipal Investigator - The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
Share this study with friends
Copy Link
Messenger